Pierre Fabre CDMO is the contract development and manufacturing arm of the Pierre Fabre Group, a French pharmaceutical and dermo-cosmetics company. Offers over 20 years of CDMO services across pharma and non-pharma active ingredients, dry forms, non-sterile liquids, and biologics including monoclonal antibodies and ADCs. Operates R&D site in Toulouse and 3+ industrial sites in France. Expertise spans extraction, chromatographic purification, chemical synthesis, cytotoxic compound production, plant cell culture, and supercritical CO2 technology. Manufactures 2,100 metric tons of plant extracts and 100+ active ingredients annually.
Oral solid dose and liquid manufacturing, cytotoxic API production, plant-based active ingredient extraction, supercritical CO2 pharmaceutical applications, monoclonal antibody and ADC manufacturing, chromatographic purification
1 site worldwide
No reviews available yet.
No documents available.